Wnt signaling pathways in urological cancers: past decades and still growing
about
Wnt Signaling in Renal Cell CarcinomaClinical and pathological implications of miRNA in bladder cancerEvaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.RASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.Evolution of network biomarkers from early to late stage bladder cancer samples.The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Array CGH Analysis of Paired Blood and Tumor Samples from Patients with Sporadic Wilms TumorOvatodiolide Targets β -Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma.Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.Molecular signatures in urologic tumors.Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerHypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.A novel non-canonical Wnt signature for prostate cancer aggressiveness.Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.Meta-analysis and gene set analysis of archived microarrays suggest implication of the spliceosome in metastatic and hypoxic phenotypes.Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions.Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells.New therapies in nonmuscle invasive bladder cancer treatment.TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.Current clinical trials in non-muscle invasive bladder cancer.Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: implications for ovarian carcinogenesis.PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells.Wnt signaling in cervical cancer?
P2860
Q26744312-0070A401-5F2C-4EF7-9006-54C21D22D6F6Q27004262-7E2D15E8-8FD1-435D-BC66-A29D7C238168Q30489412-3578C67B-EFB3-4A63-9060-0EFE62806129Q33591563-A86051E5-1980-4300-AAE9-51E81681B221Q33728900-F90417E0-5B00-4005-8CFB-C0B2AC69F823Q34306779-B3704F9D-6DCF-4811-9296-15BC9A14041CQ34699785-20650998-89CD-41DD-A53E-E8A6960A5141Q35759070-F7315B25-557C-4994-ACD4-8E747CF9B35FQ36916021-9B6226C6-4CA5-4F4F-9869-62A590495DACQ37151125-A99EE7B0-98DA-4AE6-93B2-5BB80CA66A23Q37225156-7C4EA013-EEA5-431B-BD17-D77AB2208BA3Q37627004-EABE1254-3A7E-4525-A738-D935A29D9613Q37665276-434FDF96-EDD0-445E-8866-DBC18F1EEF52Q37706021-1BA39B82-D7D1-4F50-A845-2B81E96E85CCQ38112122-533DFFD0-010A-40B9-AEAB-A4ECE1B43DD8Q38136271-131ADCB1-EA37-4290-BE97-6931740B63AEQ38393014-7F2747D1-CC43-4BBA-94AB-57E81CC5DB96Q38945181-82E11B12-9AC5-4CF5-90E2-7BE777A49263Q39367715-6D637D36-ABAF-4E05-A194-62D64A141377Q39967840-6A070485-A798-4FAC-9DF0-08E8A8C06AFEQ41309002-392FBAD0-35A4-487F-B0B1-A0211457808CQ42365286-D04C223D-B82F-4605-97E5-CC57F0A6CE27Q49519778-4CDCFC5F-543D-4659-B1AC-125C45522A58Q51320229-2C5BCE6F-3FB6-45A0-AFDE-745F2E7B0DC9Q53124991-FA81BA26-09A6-4232-BB5F-BE5BACA6740FQ53247081-AE304A29-1BC2-4903-A136-B90FD2D94AC1Q54172763-CAC7580E-9C02-4908-90BC-8F53969B1FACQ55017017-B7F1187F-22EB-4AF2-8D05-CB8AFD73321F
P2860
Wnt signaling pathways in urological cancers: past decades and still growing
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Wnt signaling pathways in urological cancers: past decades and still growing
@ast
Wnt signaling pathways in urological cancers: past decades and still growing
@en
Wnt signaling pathways in urological cancers: past decades and still growing
@en-gb
Wnt signaling pathways in urological cancers: past decades and still growing
@nl
type
label
Wnt signaling pathways in urological cancers: past decades and still growing
@ast
Wnt signaling pathways in urological cancers: past decades and still growing
@en
Wnt signaling pathways in urological cancers: past decades and still growing
@en-gb
Wnt signaling pathways in urological cancers: past decades and still growing
@nl
prefLabel
Wnt signaling pathways in urological cancers: past decades and still growing
@ast
Wnt signaling pathways in urological cancers: past decades and still growing
@en
Wnt signaling pathways in urological cancers: past decades and still growing
@en-gb
Wnt signaling pathways in urological cancers: past decades and still growing
@nl
P2093
P2860
P3181
P356
P1433
P1476
Wnt signaling pathways in urological cancers: past decades and still growing
@en
P2093
Rajvir Dahiya
Shahana Majid
Sharanjot Saini
P2860
P2888
P3181
P356
10.1186/1476-4598-11-7
P407
P5008
P577
2012-02-10T00:00:00Z
P5875
P6179
1032390647